OTC · TIHE
Taihe Group, Inc.
Healthcare · Medical - Diagnostics & Research
$1.00
Up+$0.00 (+0.00%)
Updated Aug 18, 2026, 10:36 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 71.85M
- P/E ratio
- -1,428.57
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 1
- Avg. volume
- 0.49
Price performance
TIHE price history
1M range · 0 trading sessions · Daily adjusted prices
TIHE does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest TIHE news
The latest Smart Investors Daily articles mentioning TIHE.
Stock researchCompany · Overview
TIHE research
Overview
Company profile and research snapshot.
Company profile
Taihe Group, Inc. does not have significant operations. Previously, it was operated as commercial laboratory and provided predictive chemosensitivity and immunotherapy predictive tests on biopsy tissues and other oncological laboratory testing services and products. The company was formerly known as NuOncology Labs, Inc. and changed its name to Taihe Group, Inc. in April 2022. Taihe Group, Inc. was incorporated in 1994 and is based in Scottsdale, Arizona.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
